Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.17
HSRPP's Cash to Debt is ranked higher than
68% of the 307 Companies
in the Global Medical Care industry.

( Industry Median: 0.19 vs. HSRPP: 0.17 )
HSRPP' s 10-Year Cash to Debt Range
Min: 0.01   Max: No Debt
Current: 0.17

Equity to Asset 0.16
HSRPP's Equity to Asset is ranked higher than
54% of the 307 Companies
in the Global Medical Care industry.

( Industry Median: 0.41 vs. HSRPP: 0.16 )
HSRPP' s 10-Year Equity to Asset Range
Min: -0.77   Max: 0.59
Current: 0.16

-0.77
0.59
Interest Coverage 4.80
HSRPP's Interest Coverage is ranked higher than
69% of the 199 Companies
in the Global Medical Care industry.

( Industry Median: 5.04 vs. HSRPP: 4.80 )
HSRPP' s 10-Year Interest Coverage Range
Min: 0.29   Max: 9999.99
Current: 4.8

0.29
9999.99
F-Score: 4
Z-Score: 1.50
M-Score: -3.02
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 20.40
HSRPP's Operating margin (%) is ranked higher than
95% of the 309 Companies
in the Global Medical Care industry.

( Industry Median: 8.52 vs. HSRPP: 20.40 )
HSRPP' s 10-Year Operating margin (%) Range
Min: -3.55   Max: 37.8
Current: 20.4

-3.55
37.8
Net-margin (%) 9.79
HSRPP's Net-margin (%) is ranked higher than
86% of the 309 Companies
in the Global Medical Care industry.

( Industry Median: 4.94 vs. HSRPP: 9.79 )
HSRPP' s 10-Year Net-margin (%) Range
Min: -36.52   Max: 48.3
Current: 9.79

-36.52
48.3
ROE (%) 60.70
HSRPP's ROE (%) is ranked higher than
100% of the 292 Companies
in the Global Medical Care industry.

( Industry Median: 9.59 vs. HSRPP: 60.70 )
HSRPP' s 10-Year ROE (%) Range
Min: -22.44   Max: 1312.58
Current: 60.7

-22.44
1312.58
ROA (%) 8.80
HSRPP's ROA (%) is ranked higher than
91% of the 310 Companies
in the Global Medical Care industry.

( Industry Median: 3.53 vs. HSRPP: 8.80 )
HSRPP' s 10-Year ROA (%) Range
Min: -17.98   Max: 44.36
Current: 8.8

-17.98
44.36
ROC (Joel Greenblatt) (%) 41.29
HSRPP's ROC (Joel Greenblatt) (%) is ranked higher than
88% of the 309 Companies
in the Global Medical Care industry.

( Industry Median: 17.51 vs. HSRPP: 41.29 )
HSRPP' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -17.71   Max: 129.42
Current: 41.29

-17.71
129.42
Revenue Growth (3Y)(%) 8.70
HSRPP's Revenue Growth (3Y)(%) is ranked higher than
80% of the 247 Companies
in the Global Medical Care industry.

( Industry Median: 7.20 vs. HSRPP: 8.70 )
HSRPP' s 10-Year Revenue Growth (3Y)(%) Range
Min: -27   Max: 8.7
Current: 8.7

-27
8.7
EBITDA Growth (3Y)(%) 17.30
HSRPP's EBITDA Growth (3Y)(%) is ranked higher than
87% of the 200 Companies
in the Global Medical Care industry.

( Industry Median: 6.80 vs. HSRPP: 17.30 )
HSRPP' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 0   Max: 19.8
Current: 17.3

0
19.8
EPS Growth (3Y)(%) -34.80
HSRPP's EPS Growth (3Y)(%) is ranked higher than
58% of the 193 Companies
in the Global Medical Care industry.

( Industry Median: 13.80 vs. HSRPP: -34.80 )
HSRPP' s 10-Year EPS Growth (3Y)(%) Range
Min: -47.9   Max: 56
Current: -34.8

-47.9
56
» HSRPP's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with HSRPP

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Guru Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Preferred stocks of Healthsouth Corp

SymbolPriceYieldDescription
HSRPP1415.002.306 1/2% Conv Perp Pfd Shs Series -A-
HLSHP0.000.00Conv Pfd Shs Series A -144A

Ratios

vs
industry
vs
history
P/E(ttm) 25.90
HSRPP's P/E(ttm) is ranked higher than
81% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 42.60 vs. HSRPP: 25.90 )
HSRPP' s 10-Year P/E(ttm) Range
Min: 1.71   Max: 32.2
Current: 25.9

1.71
32.2
P/B 7.81
HSRPP's P/B is ranked higher than
56% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 3.00 vs. HSRPP: 7.81 )
HSRPP' s 10-Year P/B Range
Min: 7.07   Max: 191.71
Current: 7.81

7.07
191.71
P/S 1.73
HSRPP's P/S is ranked higher than
69% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 1.60 vs. HSRPP: 1.73 )
HSRPP' s 10-Year P/S Range
Min: 0.4   Max: 3.95
Current: 1.73

0.4
3.95
PFCF 13.65
HSRPP's PFCF is ranked higher than
88% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 44.91 vs. HSRPP: 13.65 )
HSRPP' s 10-Year PFCF Range
Min: 1.77   Max: 16.49
Current: 13.65

1.77
16.49
EV-to-EBIT 10.53
HSRPP's EV-to-EBIT is ranked higher than
94% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 23.74 vs. HSRPP: 10.53 )
HSRPP' s 10-Year EV-to-EBIT Range
Min: -35.1   Max: 90.2
Current: 10.53

-35.1
90.2
PEG 1.60
HSRPP's PEG is ranked higher than
94% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 9999.00 vs. HSRPP: 1.60 )
HSRPP' s 10-Year PEG Range
Min: 1.05   Max: 2.66
Current: 1.6

1.05
2.66
Shiller P/E 12.39
HSRPP's Shiller P/E is ranked higher than
97% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 204.26 vs. HSRPP: 12.39 )
HSRPP' s 10-Year Shiller P/E Range
Min: 5.24   Max: 41.57
Current: 12.39

5.24
41.57
Current Ratio 1.52
HSRPP's Current Ratio is ranked higher than
78% of the 310 Companies
in the Global Medical Care industry.

( Industry Median: 1.32 vs. HSRPP: 1.52 )
HSRPP' s 10-Year Current Ratio Range
Min: 0.6   Max: 6.95
Current: 1.52

0.6
6.95
Quick Ratio 1.52
HSRPP's Quick Ratio is ranked higher than
81% of the 310 Companies
in the Global Medical Care industry.

( Industry Median: 1.19 vs. HSRPP: 1.52 )
HSRPP' s 10-Year Quick Ratio Range
Min: 0.6   Max: 6.95
Current: 1.52

0.6
6.95

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 2.30
HSRPP's Dividend Yield is ranked higher than
65% of the 184 Companies
in the Global Medical Care industry.

( Industry Median: 1.48 vs. HSRPP: 2.30 )
HSRPP' s 10-Year Dividend Yield Range
Min: 0.5   Max: 2.07
Current: 2.3

0.5
2.07
Yield on cost (5-Year) 2.30
HSRPP's Yield on cost (5-Year) is ranked lower than
51% of the 189 Companies
in the Global Medical Care industry.

( Industry Median: 1.99 vs. HSRPP: 2.30 )
HSRPP' s 10-Year Yield on cost (5-Year) Range
Min: 0.5   Max: 2.07
Current: 2.3

0.5
2.07
Share Buyback Rate 2.00
HSRPP's Share Buyback Rate is ranked higher than
93% of the 202 Companies
in the Global Medical Care industry.

( Industry Median: -1.40 vs. HSRPP: 2.00 )
HSRPP' s 10-Year Share Buyback Rate Range
Min: 2   Max: -34.1
Current: 2

Valuation & Return

vs
industry
vs
history
Price/DCF (Projected) 1.14
HSRPP's Price/DCF (Projected) is ranked higher than
87% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 3.63 vs. HSRPP: 1.14 )
HSRPP' s 10-Year Price/DCF (Projected) Range
Min: 0.57   Max: 209.14
Current: 1.14

0.57
209.14
Price/Median PS Value 1.54
HSRPP's Price/Median PS Value is ranked higher than
64% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 1.22 vs. HSRPP: 1.54 )
HSRPP' s 10-Year Price/Median PS Value Range
Min: 0.43   Max: 3.48
Current: 1.54

0.43
3.48
Price/Peter Lynch Fair Value 1.58
HSRPP's Price/Peter Lynch Fair Value is ranked higher than
94% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 9999.00 vs. HSRPP: 1.58 )
HSRPP' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.1   Max: 5.91
Current: 1.58

0.1
5.91
Earnings Yield (Greenblatt) 9.50
HSRPP's Earnings Yield (Greenblatt) is ranked higher than
94% of the 306 Companies
in the Global Medical Care industry.

( Industry Median: 4.60 vs. HSRPP: 9.50 )
HSRPP' s 10-Year Earnings Yield (Greenblatt) Range
Min: 1.1   Max: 16.5
Current: 9.5

1.1
16.5
Forward Rate of Return (Yacktman) 22.76
HSRPP's Forward Rate of Return (Yacktman) is ranked higher than
87% of the 213 Companies
in the Global Medical Care industry.

( Industry Median: 13.11 vs. HSRPP: 22.76 )
HSRPP' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 3.2   Max: 26.7
Current: 22.76

3.2
26.7

Business Description

Industry: Health Care Providers » Medical Care
Compare: » details
Traded in other countries:HLS.USA, HSOA.Germany,
HealthSouth Corp was organized as a Delaware corporation in February 1984. It is a provider of inpatient rehabilitative health care services in the United States. The Company's inpatient rehabilitation hospitals offer specialized rehabilitative care to diagnose and patient care services. Patient care is provided by nursing and therapy staff as directed by a physician order. As of December 31, 2013, it operated 103 inpatient rehabilitation hospitals including 2 hospitals that operate as joint ventures which it account for using the equity method of accounting, 20 outpatient rehabilitation satellite clinics operated by its hospitals and 25 licensed, hospital-based home health agencies. In addition to HealthSouth hospitals, it manages three inpatient rehabilitation units through management contracts. While it's national network of inpatient hospitals in 28 states and Puerto Rico, its inpatient hospitals are located in the eastern half of the United States and Texas. The Company's inpatient rehabilitation hospitals compete with rehabilitation units, many of which are within acute care hospitals, and skilled nursing facilities in the market. It treats patients of all ages. Its patients are persons aged 65 years and older. The Company is subject to significant federal, state, and local regulation.

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK